NL-OMON53600招募中不适用
Exploring Novel Biomarkers for Emphysema Detection: the ENBED study - ENBED
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 185
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Adults aged over 18 years
- •- current respiratory symptoms (any dyspnea, cough, or sputum)
- •- Spirometry-confirmed diagnosis of a non-fully reversible airflow obstruction
- •(defined as postbronchodilator FEV1/FVC < 0.7)
- •- chest CT scan performed in the past 12 months before the start of the study
- •- able to understand, read and write Dutch language.
排除标准
- •- acute exacerbation of COPD within 8 weeks of start of the study
- •- comorbidities affecting speech or breathing coordination (neuromuscular
- •disease, CVA)
- •- comorbidities affecting speech characteristics of dyspnea (severe heart
- •failure, interstitial lung disease)
- •- comorbidities affecting respiratory system including but not exclusive to
- •asthma or cystic fibrosis
- •- Comorbidities that significantly interfere with interpretation of speech
- •(audio signals), such as Parkinson*s disease, bulbar palsy, or vocal cord
- •- inability to carry out a capnography recording.
- •- Investigator*s uncertainty about the willingness or ability of the patients
- •to comply with the protocol requirements.
- •- Participation in another study involving investigational products.
- •Participation in observational studies is allowed.
研究者
相似试验
已完成
不适用
Markers for emphysema versus airways disease in chronic obstructive pulmonary disease (COPD)Topic: RespiratorySubtopic: Respiratory (all Subtopics)Disease: RespiratoryRespiratoryChronic obstructive pulmonary diseaseISRCTN44642272niversity Hospitals of Leicester NHS Trust (UK)1,000
招募中
不适用
Exploring Novel Biomarkers for Emphysema DetectionCopdEmphysemaNCT05825261Maastricht University200
已完成
不适用
Discovery of Novel Biomarkers in Pulmonary DiseasesPulmonary diseasesJPRN-UMIN000028108Second division, department of internal medicine, Hamamatsu University School of Medicine160
招募中
不适用
Clinical investigation of biomarkers in exhaled breath with ion mobility spectrometry (IMS) and differential mobility spectrometry (DMS)C34.0J44E84.0J84Main bronchusOther chronic obstructive pulmonary diseaseCystic fibrosis with pulmonary manifestationsOther interstitial pulmonary diseasesDRKS00000314Kooperation der Abteilung für interventionelle Pneumologie (Chefarzt PD Lutz Freitag) und der Abteilung Pneumologie-Universitätsklinik (Chefarzt Prof. Helmut Teschler) des Westdeutsches Lungenzentrum am Universitätsklinikum90
招募中
不适用
Biomarker Discovery in Exhaled Breath Condensate (EBC) to discriminate pts with lung cancer CS I-IV from pts with COPD or lung fibrosis and healthy controls.C34.9Bronchus or lung, unspecifiedDRKS00033788VOC-Advanced Breath Diagnostics GmbH238